Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077.

Authors

Elizabeth E. Tolley
Sahar Z. Zangeneh
Gordon Chau
Joe Eron
Beatriz Grinsztejn
Hilton Humphries
Albert Liu
Marc Siegel, George Washington University
Maseko Bertha
Ravindre Panchia
Sue Li
Leslie Cottle
Alex Rinehart
David Margolis
Andrea Jennings
Marybeth McCauley
Raphael J. Landovitz

Document Type

Journal Article

Publication Date

2-12-2020

Journal

AIDS and Behavior

DOI

10.1007/s10461-020-02808-2

Comments

Online ahead of print

APA Citation

Tolley, E. E., Zangeneh, S. Z., Chau, G., Eron, J., Grinsztejn, B., Humphries, H., Liu, A., Siegel, M., Bertha, M., Panchia, R., Li, S., Cottle, L., Rinehart, A., Margolis, D., Jennings, A., McCauley, M., & Landovitz, R. J. (2020). Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077.. AIDS and Behavior, (). http://dx.doi.org/10.1007/s10461-020-02808-2

Peer Reviewed

1